• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Two Memorial Sloan Kettering scientists elected to esteemed National Academy of Sciences

Bioengineer by Bioengineer
April 29, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Membership is a widely accepted mark of excellence in science and considered one of the highest honors a scientist can receive

IMAGE

Credit: Memorial Sloan Kettering Cancer Center

April 29, 2020, NEW YORK CITY — Two researchers at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI) have been elected to the National Academy of Sciences (NAS). Scott Keeney, PhD, a molecular biologist, and Christopher Lima, PhD, a structural biologist, join more than a dozen MSK investigators who are already NAS members. SKI is the research enterprise of MSK, the world’s oldest and largest private cancer center. Members are elected in recognition of their distinguished and continuing achievements in original research. Membership is one of the highest honors bestowed upon scientists worldwide.

About the Researchers

Scott Keeney, PhD, a member of SKI’s Molecular Biology Program and an Investigator of the Howard Hughes Medical Institute, is recognized for his quest to understand the mechanism of meiotic recombination and to determine how this process is coordinated with other events of meiotic prophase. Much of his focus is on the protein Spo11, which generates the double-strand breaks (DSBs) that initiate recombination, and the interactions of the Spo11 protein complex with meiotic chromosomes. His studies of Spo11 also provided an entry point to research on the DSBs made by the enzyme topoisomerase II when it is inhibited by chemotherapeutic agents such as etoposide or doxorubicin.

Christopher Lima, PhD, Chair of SKI’s Structural Biology Program and an Investigator of the Howard Hughes Medical Institute, is recognized for his work on the structural, biochemical, and functional characterization of macromolecules involved in post-translational protein modification by ubiquitin and ubiquitin-like proteins such as SUMO, and the pathways that contribute to co- and post-transcriptional RNA maturation, processing, and decay. He employs biochemical approaches to reconstitute key complexes in these pathways and combines them with single particle cryo-EM and X-ray crystallography in conjunction with genetics and biochemistry to elucidate structure/activity relationships.

The NAS is a private, nonprofit organization of the country’s leading researchers. The NAS recognizes and promotes outstanding science through election to membership; publication in its journal, PNAS; and its awards, programs, and special activities. Through the National Academies of Sciences, Engineering, and Medicine, the NAS provides objective, science-based advice on critical issues affecting the nation.

This year, NAS elected 120 new members and 26 international members in recognition of their distinguished and continuing achievements in original research. Those elected bring the total number of active members to 2,403 and the total number of international members to 501.

###

About Memorial Sloan Kettering (MSK):

As the world’s oldest and largest private cancer center, Memorial Sloan Kettering has devoted more than 135 years to exceptional patient care, influential educational programs, and innovative research to discover more effective strategies to prevent, control and, ultimately, cure cancer. MSK is home to more than 20,000 physicians, scientists, nurses, and staff united by a relentless dedication to conquering cancer. Today, we are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for our patients. We also train the next generation of clinical and scientific leaders in oncology through our continually evolving educational programs, here and around the world. Year after year, we are ranked among the top two cancer hospitals in the country, consistently recognized for our expertise in adult and pediatric oncology specialties. http://www.mskcc.org.

Media Contact
Rebecca Williams
[email protected]

Tags: BiologyDevelopmental/Reproductive BiologyMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

Mn-Zn Ferrite Nanoparticles Combat CML Resistance via Ferroptosis

October 8, 2025

Unraveling 2p25 Prostate Cancer Risk Mechanisms

October 8, 2025

Sit-Up Test Evaluates Blood Pressure in Seniors

October 8, 2025

Maximizing ROI in Mental Healthcare Quality Improvement

October 8, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1070 shares
    Share 428 Tweet 267
  • New Study Reveals the Science Behind Exercise and Weight Loss

    100 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    95 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    79 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mn-Zn Ferrite Nanoparticles Combat CML Resistance via Ferroptosis

Early-Life Exposures Linked to Blood Cancers

Unraveling 2p25 Prostate Cancer Risk Mechanisms

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.